Impact of TRIPS and RTAs on the Indian Pharmaceutical Product Exports

Bishwanjit Loitongbam ()

MPRA Paper from University Library of Munich, Germany

Abstract: Until India fully implemented TRIPS in 2005, the Indian pharmaceutical industry had maintained a comparative advantage of cheap and skilled workers among developing economies. However, recent changes in regulatory environment have made the situation challenging for the industry. India seems to be losing its position in the global arena in both the production of bulk drugs and formulations. This paper investigates how TRIPS (implemented by partner countries) and Regional Trade Agreements (RTAs) influence Indian pharmaceutical product exports, using the Gravity Model. This analysis finds that TRIPS has negative effect on Indian pharmaceutical products exports. And RTAs increase pharmaceutical products exports.

Keywords: TRIPS; RTA; Gravity Model; Indian Pharmaceutical Industry (search for similar items in EconPapers)
JEL-codes: F13 F14 F6 F68 (search for similar items in EconPapers)
Date: 2016-03-07, Revised 2016-05-27
New Economics Papers: this item is included in nep-int
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/75764/1/MPRA_paper_75764.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:75764

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().